Selected article for: "lupus erythematosus and rheumatoid arthritis"
Author: Ferraccioli, Edoardo Sean; Gremese, Elisa; Ferraccioli, Gianfranco
Title: Children's (and autoimmune patients) morbidity (and mortality) from Covid‐19 is similar to the general population: immunologic rationale.
  • Cord-id: e4dcisv2
  • Document date: 2020_6_17
    • ID: e4dcisv2
    Snippet: We read with great interest the Viewpoint by L. H Henderson et al (1) on the therapeutic approach with Glucocorticoids (GC) to the inflammation and Cytokine Storm phases of SARS.CoV 2 infection. We would like to expand their analysis and discuss the data , so far reported in Children and Autoimmune patients ( Rheumatoid Arthritis , Systemic Lupus Erythematosus), about the chance of undergoing a "severe" infection. So far children (and autoimmune patients) , who should be extremely fragile, rarel
    Document: We read with great interest the Viewpoint by L. H Henderson et al (1) on the therapeutic approach with Glucocorticoids (GC) to the inflammation and Cytokine Storm phases of SARS.CoV 2 infection. We would like to expand their analysis and discuss the data , so far reported in Children and Autoimmune patients ( Rheumatoid Arthritis , Systemic Lupus Erythematosus), about the chance of undergoing a "severe" infection. So far children (and autoimmune patients) , who should be extremely fragile, rarely entered into the third phase "the cytokine release syndrome‐CRS " of COVID‐19, leading only some patients to the Intensive Care Units (ICUs).

    Search related documents:
    Co phrase search for related documents
    • acute ards respiratory distress syndrome and lung increase inflammation: 1
    • acute ards respiratory distress syndrome and lung inflammation: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72
    • acute ards respiratory distress syndrome and lung integrity: 1, 2, 3, 4
    • acute ards respiratory distress syndrome and lymphoid cells: 1, 2
    • acute ards respiratory distress syndrome and macrophage activation: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24
    • acute ards respiratory distress syndrome and macrophage activation syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
    • acute ards respiratory distress syndrome target and lung inflammation: 1
    • acute ards respiratory distress syndrome target and macrophage activation: 1
    • lung inflammation and lymphocyte number: 1, 2
    • lung inflammation and lymphoid cells: 1, 2, 3, 4, 5, 6, 7, 8
    • lung inflammation and macrophage activation: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • lung inflammation and macrophage activation syndrome: 1, 2
    • lung integrity and lymphoid cells: 1
    • lymphocyte number and macrophage activation: 1
    • lymphoid cells and macrophage activation: 1